iShares Health Innovation Active ETF (BMED)
NYSEARCA: BMED · Real-Time Price · USD
28.63
-0.15 (-0.52%)
Mar 13, 2026, 4:00 PM EDT - Market closed
BMED Holdings Information
BMED is an equity ETF with a total of 55 individual holdings. The top holdings are Johnson & Johnson stock at 7.91%, Amgen at 4.66%, Edwards Lifesciences at 4.57%, Merck & Co. at 4.56%, and McKesson at 4.52%.
Total Holdings
55
Top 10 Percentage
44.67%
Asset Class
Equity
ETF Category
Health
Assets
10.38M
PE Ratio
16.71
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | 7.91% |
| 2 | AMGN | Amgen Inc. | 4.66% |
| 3 | EW | Edwards Lifesciences Corporation | 4.57% |
| 4 | MRK | Merck & Co., Inc. | 4.56% |
| 5 | MCK | McKesson Corporation | 4.52% |
| 6 | COR | Cencora, Inc. | 4.44% |
| 7 | XTSLA | BLK CSH FND TREASURY SL AGENCY | 4.33% |
| 8 | GILD | Gilead Sciences, Inc. | 3.52% |
| 9 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 3.22% |
| 10 | MRNA | Moderna, Inc. | 2.93% |
| 11 | DHR | Danaher Corporation | 2.83% |
| 12 | WAT | Waters Corporation | 2.77% |
| 13 | MTD | Mettler-Toledo International Inc. | 2.71% |
| 14 | CRL | Charles River Laboratories International, Inc. | 2.57% |
| 15 | ISRG | Intuitive Surgical, Inc. | 2.50% |
| 16 | ARGX | argenx SE | 2.46% |
| 17 | SWX: NOVN | Novartis AG | 2.30% |
| 18 | BIIB | Biogen Inc. | 2.29% |
| 19 | DXCM | DexCom, Inc. | 2.16% |
| 20 | BRKR | Bruker Corporation | 2.12% |
| 21 | GSK | GSK plc | 2.02% |
| 22 | VRTX | Vertex Pharmaceuticals Incorporated | 1.91% |
| 23 | TECH | Bio-Techne Corporation | 1.85% |
| 24 | PTGX | Protagonist Therapeutics, Inc. | 1.83% |
| 25 | USD | USD CASH | 1.78% |
As of Mar 12, 2026